Regeneron Pharmaceuticals, Inc. vs Larsen & Toubro Limited
Market cap comparison over time
Regeneron Pharmaceuticals, Inc.
$63.0B
Rank #231
Larsen & Toubro Limited
$64.9B
Rank #227
Market Cap Over Time
Key Moments
- Larsen & Toubro Limited overtook Regeneron Pharmaceuticals, Inc. by 2004
- Regeneron Pharmaceuticals, Inc. overtook Larsen & Toubro Limited by 2012
- Larsen & Toubro Limited overtook Regeneron Pharmaceuticals, Inc. by 2026
Year-by-Year Comparison
| Year | Regeneron Pharmaceuticals, Inc. | Larsen & Toubro Limited | Leader |
|---|---|---|---|
| 2026 | $63.0B | $64.9B | Larsen & Toubro Limited |
| 2025 | $79.3B | $66.8B | Regeneron Pharmaceuticals, Inc. |
| 2024 | $72.8B | $58.4B | Regeneron Pharmaceuticals, Inc. |
| 2023 | $89.7B | $56.7B | Regeneron Pharmaceuticals, Inc. |
| 2022 | $73.7B | $33.1B | Regeneron Pharmaceuticals, Inc. |
| 2021 | $64.5B | $29.7B | Regeneron Pharmaceuticals, Inc. |
| 2020 | $49.4B | $20.0B | Regeneron Pharmaceuticals, Inc. |
| 2019 | $38.4B | $19.3B | Regeneron Pharmaceuticals, Inc. |
| 2018 | $38.2B | $21.1B | Regeneron Pharmaceuticals, Inc. |
| 2017 | $38.4B | $18.2B | Regeneron Pharmaceuticals, Inc. |
| 2016 | $37.5B | $12.7B | Regeneron Pharmaceuticals, Inc. |
| 2015 | $55.5B | $11.9B | Regeneron Pharmaceuticals, Inc. |
| 2014 | $41.9B | $13.8B | Regeneron Pharmaceuticals, Inc. |
| 2013 | $28.1B | $9.8B | Regeneron Pharmaceuticals, Inc. |
| 2012 | $17.5B | $9.6B | Regeneron Pharmaceuticals, Inc. |
| 2011 | $5.7B | $5.9B | Larsen & Toubro Limited |
| 2010 | $3.4B | $11.6B | Larsen & Toubro Limited |
| 2009 | $2.5B | $9.8B | Larsen & Toubro Limited |
| 2008 | $1.9B | $4.5B | Larsen & Toubro Limited |
| 2007 | $2.5B | $12.0B | Larsen & Toubro Limited |
| 2006 | $2.1B | $4.1B | Larsen & Toubro Limited |
| 2005 | $1.6B | $2.6B | Larsen & Toubro Limited |
| 2004 | $941.1M | $1.4B | Larsen & Toubro Limited |
| 2003 | $1.5B | $1.4B | Regeneron Pharmaceuticals, Inc. |
| 2002 | $1.9B | $576.7M | Regeneron Pharmaceuticals, Inc. |